| Unternehmen / Aktien | News 24 h | News 7 T | Kurs | ||
|---|---|---|---|---|---|
| BIONTECH | 8 | 13 | +2,50 % | ||
| MINERALYS THERAPEUTICS | 8 | 1 | -3,04 % | ||
| APELLIS PHARMACEUTICALS | 7 | 4 | +1,67 % | ||
| CORVUS PHARMACEUTICALS | 6 | - | +4,87 % | ||
| IMMUNITYBIO | 5 | 3 | +6,71 % | ||
| AC IMMUNE | 5 | - | +1,54 % | ||
| GILEAD SCIENCES | 4 | 5 | +0,33 % | ||
| INDIVIOR PHARMACEUTICALS | 4 | 4 | +1,50 % | ||
| SAVARA | 4 | - | +6,03 % | ||
| SANA BIOTECHNOLOGY | 4 | - | +8,89 % |
| Zeit | Aktuelle Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
|---|---|---|---|---|---|
| 21:54 | BofA raises CG Oncology stock price target to $72 on market share outlook | 4 | Investing.com | ||
| 21:54 | CG Oncology stock rating reiterated at Buy by Truist Securities | 1 | Investing.com | ||
| 21:43 | Evolus, Inc. - 8-K, Current Report | 1 | SEC Filings | ||
| 21:26 | Dyne Therapeutics (DYN) Shares Key Details For Pivotal. Drugs | 1 | Insider Monkey | ||
| 21:26 | Tango Therapeutics' (TNGX) Sees Cautious Analyst Optimism Following Earnings | 1 | Insider Monkey | ||
| 21:26 | Mineralys Therapeutics (MLYS) Makes Progress With FDA For Hypertension | 1 | Insider Monkey | ||
| 20:36 | Savara GAAP EPS of -$0.13 | 5 | Seeking Alpha | ||
| 19:34 | SIGA Technologies - Business strength intact, timing risk overdone | 191 | Edison Investment Research | Following a strong H125, driven by c $85m in TPOXX deliveries, H225 was expectedly softer, which we view as a function of SIGA's inherently lumpy procurement-driven model rather than any deterioration... ► Artikel lesen | |
| 19:18 | Morgan Stanley reiterates Sana Biotechnology stock rating on diabetes data | 1 | Investing.com | ||
| 18:58 | Jefferies senkt Kursziel für Mineralys Therapeutics wegen Bedenken bei Medikament | 3 | Investing.com Deutsch | ||
| 18:30 | Jefferies cuts Mineralys Therapeutics price target on drug concerns | 2 | Investing.com | ||
| 18:12 | ImmunityBio rises after updates on cell therapy programs | 25 | Seeking Alpha | ||
| 18:10 | IBRX and the BCG Shortage: A 2026 Catalyst Investors Are Tracking | 6 | Zacks | ||
| 18:10 | ImmunityBio Valuation: Paying 33x Sales for Anktiva | 8 | Zacks | ||
| 18:10 | IBRX Stock: Anktiva's Approvals and What Comes Next | 3 | Zacks | ||
| 18:10 | GSK catches up to Pfizer, Moderna with FDA expansion for Arexvy | 25 | FiercePharma | ||
| 17:38 | DEFINIUM THERAPEUTICS INC: Schwäche mit Signalwert | 5 | Maximilian Berger | ||
| 17:15 | Dividendenbekanntmachungen (13.03.2026) | 4.034 | wallstreetONLINE (Dividenden) | Unternehmen ISIN-Code Dividende (Währung) Dividende (EUR) ACADIAN ASSET MANAGEMENT INC US10948W1036 0,1 USD 0,0868 EUR ALBEMARLE CORPORATION US0126531013 0,405 USD 0,3516 EUR ALEXANDRIA... ► Artikel lesen | |
| 16:54 | Ausblick auf Gilead Sciences - Korrekturmodus | Société Générale | |||
| 16:48 | Apellis wins new Buy at Roth on Syfovre prospects | 2 | Seeking Alpha |